PER 1.18% 8.4¢ percheron therapeutics limited

chop shop ? all the secondary endpoints showed improvement it...

  1. 35,674 Posts.
    lightbulb Created with Sketch. 548
    chop shop ?

    all the secondary endpoints showed improvement it was only the primary endpoint that missed

    Pfizer on the other hand the secondary endpoints showed nothing

    I mean the writing was on the wall from the start unless you listened to itsgas - the “failure” was backed with all positives outside of the primary hence the flash crash ….

    I mean if you couldn’t see the obvious at the start the fact Roche initiated Elevidy’s marketing authorisation applications in Europe first half of this year only highlighted their opinion on those secondary endpoints pulling it through.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
-0.001(1.18%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.